Subscribe To
Recursion is granted fda fast track designation for rec-2282 for the potential treatment of nf2-mutated meningiomas
SALT LAKE CITY, Oct. 7, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technol...
October 7, 2021, 7:55 am
Recursion is granted fda fast track designation for rec-2282 for the potential treatment of nf2-mutated meningiomas
SALT LAKE CITY, Oct. 7, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technol...
October 7, 2021, 7:55 am
Forma therapeutics' ft-7051 is well-tolerated and demonstrates evidence of activity in initial results from ongoing phase 1 courage study in men with metastatic castration-resistant prostate cancer
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell...
October 7, 2021, 7:05 am
Forma therapeutics' ft-7051 is well-tolerated and demonstrates evidence of activity in initial results from ongoing phase 1 courage study in men with metastatic castration-resistant prostate cancer
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell...
October 7, 2021, 7:05 am
Forma therapeutics' ft-7051 is well-tolerated and demonstrates evidence of activity in initial results from ongoing phase 1 courage study in men with metastatic castration-resistant prostate cancer
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell...
October 7, 2021, 7:05 am
Cue health, google cloud join forces to track respiratory viral variants
Cue Health Inc (NASDAQ: HLTH) will collaborate with Google Cloud to add respiratory viral variant sequencing and tracking to its Cue Integrated Car...
October 6, 2021, 12:33 pm
Cue health, google cloud join forces to track respiratory viral variants
Cue Health Inc (NASDAQ: HLTH) will collaborate with Google Cloud to add respiratory viral variant sequencing and tracking to its Cue Integrated Car...
October 6, 2021, 12:33 pm
Cue health, google cloud join forces to track respiratory viral variants
Cue Health Inc (NASDAQ: HLTH) will collaborate with Google Cloud to add respiratory viral variant sequencing and tracking to its Cue Integrated Car...
October 6, 2021, 12:33 pm
Co-diagnostics jv cosara receives clearance from indian regulators for dengue/chikungunya multiplex test
SALT LAKE CITY, Oct. 6, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a mole...
October 6, 2021, 10:54 am
Co-diagnostics jv cosara receives clearance from indian regulators for dengue/chikungunya multiplex test
SALT LAKE CITY, Oct. 6, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a mole...
October 6, 2021, 10:54 am
Co-diagnostics jv cosara receives clearance from indian regulators for dengue/chikungunya multiplex test
SALT LAKE CITY, Oct. 6, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a mole...
October 6, 2021, 10:54 am
Cue health collaborates with google cloud to add variant sequencing, tracking, and predictive capabilities to its cue platform
SAN DIEGO, Oct. 6, 2021 /PRNewswire/ -- Cue Health Inc. (Nasdaq: HLTH), a mission-driven healthcare technology company, today introduced its new col...
October 6, 2021, 9:15 am
Cue health collaborates with google cloud to add variant sequencing, tracking, and predictive capabilities to its cue platform
SAN DIEGO, Oct. 6, 2021 /PRNewswire/ -- Cue Health Inc. (Nasdaq: HLTH), a mission-driven healthcare technology company, today introduced its new col...
October 6, 2021, 9:15 am
Cue health collaborates with google cloud to add variant sequencing, tracking, and predictive capabilities to its cue platform
SAN DIEGO, Oct. 6, 2021 /PRNewswire/ -- Cue Health Inc. (Nasdaq: HLTH), a mission-driven healthcare technology company, today introduced its new col...
October 6, 2021, 9:15 am
Lexagene to webcast live at virtualinvestorconferences.com october 7th
BEVERLY, Mass., Oct. 6, 2021 /PRNewswire/ -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) ("LexaGene" or the "Company"), a commercial ...
October 6, 2021, 8:32 am
Lexagene to webcast live at virtualinvestorconferences.com october 7th
BEVERLY, Mass., Oct. 6, 2021 /PRNewswire/ -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) ("LexaGene" or the "Company"), a commercial ...
October 6, 2021, 8:32 am
Lexagene to webcast live at virtualinvestorconferences.com october 7th
BEVERLY, Mass., Oct. 6, 2021 /PRNewswire/ -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) ("LexaGene" or the "Company"), a commercial ...
October 6, 2021, 8:32 am
4d molecular to test its wet amd gene therapy in patients
The FDA has signed off 4D molecular Therapeutics' (NASDAQ: FDMT) Investigational New Drug Applicatio...
October 6, 2021, 8:27 am
4d molecular to test its wet amd gene therapy in patients
The FDA has signed off 4D molecular Therapeutics' (NASDAQ: FDMT) Investigational New Drug Applicatio...
October 6, 2021, 8:27 am
4d molecular to test its wet amd gene therapy in patients
The FDA has signed off 4D molecular Therapeutics' (NASDAQ: FDMT) Investigational New Drug Applicatio...
October 6, 2021, 8:27 am